348 related articles for article (PubMed ID: 26686626)
1. Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents.
Wang P; Wu J; Ma S; Zhang L; Yao J; Hoadley KA; Wilkerson MD; Perou CM; Guan KL; Ye D; Xiong Y
Cell Rep; 2015 Dec; 13(11):2353-2361. PubMed ID: 26686626
[TBL] [Abstract][Full Text] [Related]
2. D-2-Hydroxyglutarate in Glioma Biology.
Chou FJ; Liu Y; Lang F; Yang C
Cells; 2021 Sep; 10(9):. PubMed ID: 34571995
[TBL] [Abstract][Full Text] [Related]
3. Oncometabolites d- and l-2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions.
Chen F; Bian K; Tang Q; Fedeles BI; Singh V; Humulock ZT; Essigmann JM; Li D
Chem Res Toxicol; 2017 Apr; 30(4):1102-1110. PubMed ID: 28269980
[TBL] [Abstract][Full Text] [Related]
4. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
Xu W; Yang H; Liu Y; Yang Y; Wang P; Kim SH; Ito S; Yang C; Wang P; Xiao MT; Liu LX; Jiang WQ; Liu J; Zhang JY; Wang B; Frye S; Zhang Y; Xu YH; Lei QY; Guan KL; Zhao SM; Xiong Y
Cancer Cell; 2011 Jan; 19(1):17-30. PubMed ID: 21251613
[TBL] [Abstract][Full Text] [Related]
5. Targeting isocitrate dehydrogenase (IDH) in cancer.
Fujii T; Khawaja MR; DiNardo CD; Atkins JT; Janku F
Discov Med; 2016 May; 21(117):373-80. PubMed ID: 27355333
[TBL] [Abstract][Full Text] [Related]
6. Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
Evans B; Griner E;
Elife; 2015 Jul; 4():e07420. PubMed ID: 26231040
[TBL] [Abstract][Full Text] [Related]
7. Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage.
Li Q; Huang Y; Liu X; Gan J; Chen H; Yang CG
J Biol Chem; 2016 May; 291(21):11083-93. PubMed ID: 27015802
[TBL] [Abstract][Full Text] [Related]
8. Alkbh2 protects against lethality and mutation in primary mouse embryonic fibroblasts.
Nay SL; Lee DH; Bates SE; O'Connor TR
DNA Repair (Amst); 2012 May; 11(5):502-10. PubMed ID: 22429847
[TBL] [Abstract][Full Text] [Related]
9. Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase.
Zhao Y; Majid MC; Soll JM; Brickner JR; Dango S; Mosammaparast N
EMBO J; 2015 Jun; 34(12):1687-703. PubMed ID: 25944111
[TBL] [Abstract][Full Text] [Related]
10. D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth.
Ma S; Jiang B; Deng W; Gu ZK; Wu FZ; Li T; Xia Y; Yang H; Ye D; Xiong Y; Guan KL
Oncotarget; 2015 Apr; 6(11):8606-20. PubMed ID: 25825982
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates.
Ye D; Guan KL; Xiong Y
Trends Cancer; 2018 Feb; 4(2):151-165. PubMed ID: 29458964
[TBL] [Abstract][Full Text] [Related]
12. D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced
Li T; Cox CD; Ozer BH; Nguyen NT; Nguyen HN; Lai TJ; Li S; Liu F; Kornblum HI; Liau LM; Nghiemphu PL; Cloughesy TF; Lai A
Mol Cancer Res; 2018 Jun; 16(6):947-960. PubMed ID: 29545476
[TBL] [Abstract][Full Text] [Related]
13. Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
Li L; Paz AC; Wilky BA; Johnson B; Galoian K; Rosenberg A; Hu G; Tinoco G; Bodamer O; Trent JC
PLoS One; 2015; 10(9):e0133813. PubMed ID: 26368816
[TBL] [Abstract][Full Text] [Related]
14. Bacterial DNA repair genes and their eukaryotic homologues: 3. AlkB dioxygenase and Ada methyltransferase in the direct repair of alkylated DNA.
Nieminuszczy J; Grzesiuk E
Acta Biochim Pol; 2007; 54(3):459-68. PubMed ID: 17823664
[TBL] [Abstract][Full Text] [Related]
15. Beyond Isocitrate Dehydrogenase Mutations: Emerging Mechanisms for the Accumulation of the Oncometabolite 2-Hydroxyglutarate.
Peng S; Chen H; Chen L; Yang G; Liu J; Cheng X; Tang Y
Chem Res Toxicol; 2022 Feb; 35(2):115-124. PubMed ID: 35018778
[TBL] [Abstract][Full Text] [Related]
16. Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation.
Fujiwara H; Tateishi K; Misumi K; Hayashi A; Igarashi K; Kato H; Nakatsuka T; Suzuki N; Yamamoto K; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Ijichi H; Kogure H; Nakai Y; Isayama H; Hasegawa K; Fukayama M; Soga T; Koike K
Sci Rep; 2019 Dec; 9(1):18859. PubMed ID: 31827136
[TBL] [Abstract][Full Text] [Related]
17. Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes.
Tran TQ; Ishak Gabra MB; Lowman XH; Yang Y; Reid MA; Pan M; O'Connor TR; Kong M
PLoS Biol; 2017 Nov; 15(11):e2002810. PubMed ID: 29107960
[TBL] [Abstract][Full Text] [Related]
18. D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells.
Zhang L; Sorensen MD; Kristensen BW; Reifenberger G; McIntyre TM; Lin F
Clin Cancer Res; 2018 Nov; 24(21):5381-5391. PubMed ID: 30006485
[No Abstract] [Full Text] [Related]
19. D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH.
Oizel K; Gratas C; Nadaradjane A; Oliver L; Vallette FM; Pecqueur C
Cell Death Dis; 2015 Mar; 6(3):e1704. PubMed ID: 25811801
[TBL] [Abstract][Full Text] [Related]
20. 2-Hydoxyglutarate: D/Riving Pathology in gLiomaS.
Wahl DR; Venneti S
Brain Pathol; 2015 Nov; 25(6):760-8. PubMed ID: 26526944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
